APO Research

APO RESEARCH · REPORT

Mefenamic Acid

Selected research

Market Analysis & Forecast

Global Mefenamic Acid Market Analysis and Forecast 2026-2032

Market perspective

The global Mefenamic Acid market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Mefenamic Acid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Mefenamic Acid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Mefenamic Acid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Mefenamic Acid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Mefenamic Acid include AA Pharma, ABL Lifecare, Adelco, Agron Remedies, Apotex, Captab, Chemidex Pharma, Daiichi Sankyo and EMS Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Mefenamic Acid, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Mefenamic Acid, also provides the sales of main regions and countries. Of the upcoming market potential for Mefenamic Acid, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mefenamic Acid sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mefenamic Acid market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Mefenamic Acid sales, projected growth trends, production technology, application and end-user industry.

Mefenamic Acid Segment by Company

AA Pharma

ABL Lifecare

Adelco

Agron Remedies

Apotex

Captab

Chemidex Pharma

Daiichi Sankyo

EMS Pharma

Esteve

Farmo Quimica

IASIS Pharmaceuticals Hellas

Koa Isei

Mankind

Nisshin Pharmaceutical

Sanofi Aventis

Shinto Organics

Shionogi Pharma

Solitaire Pharmacia

Streuli Pharma,

Wockhardt

Yung Sine

Pfizer

Teva

Mefenamic Acid Segment by Type

Patent

Generic

Mefenamic Acid Segment by Application

On-line

Drug Store

Hospital

Mefenamic Acid Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mefenamic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mefenamic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mefenamic Acid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Mefenamic Acid in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Mefenamic Acid manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mefenamic Acid sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mefenamic Acid Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Patent Major Manufacturers Table 3. Generic Major Manufacturers Table 4. Global Mefenamic Acid Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. On-line Major Manufacturers Table 6. Drug Store Major Manufacturers Table 7. Hospital Major Manufacturers Table 8. Mefenamic Acid Industry Trends Table 9. Mefenamic Acid Industry Drivers Table 10. Mefenamic Acid Industry Opportunities and Challenges Table 11. Mefenamic Acid Industry Restraints Table 12. Global Mefenamic Acid Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Mefenamic Acid Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Mefenamic Acid Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Mefenamic Acid Revenue Market Share by Region (2021-2026) Table 16. Global Mefenamic Acid Revenue Market Share by Region (2027-2032) Table 17. Global Mefenamic Acid Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Mefenamic Acid Sales by Region (2021-2026) & (K Units) Table 19. Global Mefenamic Acid Sales by Region (2027-2032) & (K Units) Table 20. Global Mefenamic Acid Sales Market Share by Region (2021-2026) Table 21. Global Mefenamic Acid Sales Market Share by Region (2027-2032) Table 22. Global Mefenamic Acid Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Mefenamic Acid Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Mefenamic Acid Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Mefenamic Acid Sales Market Share by Manufacturers (2021-2026) Table 26. Global Mefenamic Acid Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Mefenamic Acid Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Mefenamic Acid Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Mefenamic Acid Manufacturers, Product Type & Application Table 30. Global Mefenamic Acid Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Mefenamic Acid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Mefenamic Acid Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Mefenamic Acid Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Mefenamic Acid Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Mefenamic Acid Revenue Market Share by Type (2021-2026) Table 37. Global Mefenamic Acid Revenue Market Share by Type (2027-2032) Table 38. Global Mefenamic Acid Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 40. Global Mefenamic Acid Sales by Type (2027-2032) & (K Units) Table 41. Global Mefenamic Acid Sales Market Share by Type (2021-2026) Table 42. Global Mefenamic Acid Sales Market Share by Type (2027-2032) Table 43. Global Mefenamic Acid Price by Type (2021-2026) & (US$/Unit) Table 44. Global Mefenamic Acid Price by Type (2027-2032) & (US$/Unit) Table 45. Global Mefenamic Acid Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Mefenamic Acid Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Mefenamic Acid Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Mefenamic Acid Revenue Market Share by Application (2021-2026) Table 49. Global Mefenamic Acid Revenue Market Share by Application (2027-2032) Table 50. Global Mefenamic Acid Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 52. Global Mefenamic Acid Sales by Application (2027-2032) & (K Units) Table 53. Global Mefenamic Acid Sales Market Share by Application (2021-2026) Table 54. Global Mefenamic Acid Sales Market Share by Application (2027-2032) Table 55. Global Mefenamic Acid Price by Application (2021-2026) & (US$/Unit) Table 56. Global Mefenamic Acid Price by Application (2027-2032) & (US$/Unit) Table 57. AA Pharma Company Information Table 58. AA Pharma Business Overview Table 59. AA Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. AA Pharma Mefenamic Acid Product Portfolio Table 61. AA Pharma Recent Development Table 62. ABL Lifecare Company Information Table 63. ABL Lifecare Business Overview Table 64. ABL Lifecare Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. ABL Lifecare Mefenamic Acid Product Portfolio Table 66. ABL Lifecare Recent Development Table 67. Adelco Company Information Table 68. Adelco Business Overview Table 69. Adelco Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Adelco Mefenamic Acid Product Portfolio Table 71. Adelco Recent Development Table 72. Agron Remedies Company Information Table 73. Agron Remedies Business Overview Table 74. Agron Remedies Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Agron Remedies Mefenamic Acid Product Portfolio Table 76. Agron Remedies Recent Development Table 77. Apotex Company Information Table 78. Apotex Business Overview Table 79. Apotex Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Apotex Mefenamic Acid Product Portfolio Table 81. Apotex Recent Development Table 82. Captab Company Information Table 83. Captab Business Overview Table 84. Captab Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Captab Mefenamic Acid Product Portfolio Table 86. Captab Recent Development Table 87. Chemidex Pharma Company Information Table 88. Chemidex Pharma Business Overview Table 89. Chemidex Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Chemidex Pharma Mefenamic Acid Product Portfolio Table 91. Chemidex Pharma Recent Development Table 92. Daiichi Sankyo Company Information Table 93. Daiichi Sankyo Business Overview Table 94. Daiichi Sankyo Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Daiichi Sankyo Mefenamic Acid Product Portfolio Table 96. Daiichi Sankyo Recent Development Table 97. EMS Pharma Company Information Table 98. EMS Pharma Business Overview Table 99. EMS Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. EMS Pharma Mefenamic Acid Product Portfolio Table 101. EMS Pharma Recent Development Table 102. Esteve Company Information Table 103. Esteve Business Overview Table 104. Esteve Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Esteve Mefenamic Acid Product Portfolio Table 106. Esteve Recent Development Table 107. Farmo Quimica Company Information Table 108. Farmo Quimica Business Overview Table 109. Farmo Quimica Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Farmo Quimica Mefenamic Acid Product Portfolio Table 111. Farmo Quimica Recent Development Table 112. IASIS Pharmaceuticals Hellas Company Information Table 113. IASIS Pharmaceuticals Hellas Business Overview Table 114. IASIS Pharmaceuticals Hellas Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolio Table 116. IASIS Pharmaceuticals Hellas Recent Development Table 117. Koa Isei Company Information Table 118. Koa Isei Business Overview Table 119. Koa Isei Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Koa Isei Mefenamic Acid Product Portfolio Table 121. Koa Isei Recent Development Table 122. Mankind Company Information Table 123. Mankind Business Overview Table 124. Mankind Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Mankind Mefenamic Acid Product Portfolio Table 126. Mankind Recent Development Table 127. Nisshin Pharmaceutical Company Information Table 128. Nisshin Pharmaceutical Business Overview Table 129. Nisshin Pharmaceutical Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Nisshin Pharmaceutical Mefenamic Acid Product Portfolio Table 131. Nisshin Pharmaceutical Recent Development Table 132. Sanofi Aventis Company Information Table 133. Sanofi Aventis Business Overview Table 134. Sanofi Aventis Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Sanofi Aventis Mefenamic Acid Product Portfolio Table 136. Sanofi Aventis Recent Development Table 137. Shinto Organics Company Information Table 138. Shinto Organics Business Overview Table 139. Shinto Organics Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Shinto Organics Mefenamic Acid Product Portfolio Table 141. Shinto Organics Recent Development Table 142. Shionogi Pharma Company Information Table 143. Shionogi Pharma Business Overview Table 144. Shionogi Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Shionogi Pharma Mefenamic Acid Product Portfolio Table 146. Shionogi Pharma Recent Development Table 147. Solitaire Pharmacia Company Information Table 148. Solitaire Pharmacia Business Overview Table 149. Solitaire Pharmacia Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Solitaire Pharmacia Mefenamic Acid Product Portfolio Table 151. Solitaire Pharmacia Recent Development Table 152. Streuli Pharma, Company Information Table 153. Streuli Pharma, Business Overview Table 154. Streuli Pharma, Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Streuli Pharma, Mefenamic Acid Product Portfolio Table 156. Streuli Pharma, Recent Development Table 157. Wockhardt Company Information Table 158. Wockhardt Business Overview Table 159. Wockhardt Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Wockhardt Mefenamic Acid Product Portfolio Table 161. Wockhardt Recent Development Table 162. Yung Sine Company Information Table 163. Yung Sine Business Overview Table 164. Yung Sine Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Yung Sine Mefenamic Acid Product Portfolio Table 166. Yung Sine Recent Development Table 167. Pfizer Company Information Table 168. Pfizer Business Overview Table 169. Pfizer Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Pfizer Mefenamic Acid Product Portfolio Table 171. Pfizer Recent Development Table 172. Teva Company Information Table 173. Teva Business Overview Table 174. Teva Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Teva Mefenamic Acid Product Portfolio Table 176. Teva Recent Development Table 177. North America Mefenamic Acid Revenue by Type (2021-2026) & (US$ Million) Table 178. North America Mefenamic Acid Revenue by Type (2027-2032) & (US$ Million) Table 179. North America Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 180. North America Mefenamic Acid Sales by Type (2027-2032) & (K Units) Table 181. North America Mefenamic Acid Sales Price by Type (2021-2026) & (US$/Unit) Table 182. North America Mefenamic Acid Sales Price by Type (2027-2032) & (US$/Unit) Table 183. North America Mefenamic Acid Revenue by Application (2021-2026) & (US$ Million) Table 184. North America Mefenamic Acid Revenue by Application (2027-2032) & (US$ Million) Table 185. North America Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 186. North America Mefenamic Acid Sales by Application (2027-2032) & (K Units) Table 187. North America Mefenamic Acid Sales Price by Application (2021-2026) & (US$/Unit) Table 188. North America Mefenamic Acid Sales Price by Application (2027-2032) & (US$/Unit) Table 189. North America Mefenamic Acid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. North America Mefenamic Acid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. North America Mefenamic Acid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. North America Mefenamic Acid Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 193. North America Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 194. North America Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 195. North America Mefenamic Acid Sales Price by Country (2021-2026) & (US$/Unit) Table 196. North America Mefenamic Acid Sales Price by Country (2027-2032) & (US$/Unit) Table 197. United States Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 198. Canada Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 199. Europe Mefenamic Acid Revenue by Type (2021-2026) & (US$ Million) Table 200. Europe Mefenamic Acid Revenue by Type (2027-2032) & (US$ Million) Table 201. Europe Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 202. Europe Mefenamic Acid Sales by Type (2027-2032) & (K Units) Table 203. Europe Mefenamic Acid Sales Price by Type (2021-2026) & (US$/Unit) Table 204. Europe Mefenamic Acid Sales Price by Type (2027-2032) & (US$/Unit) Table 205. Europe Mefenamic Acid Revenue by Application (2021-2026) & (US$ Million) Table 206. Europe Mefenamic Acid Revenue by Application (2027-2032) & (US$ Million) Table 207. Europe Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 208. Europe Mefenamic Acid Sales by Application (2027-2032) & (K Units) Table 209. Europe Mefenamic Acid Sales Price by Application (2021-2026) & (US$/Unit) Table 210. Europe Mefenamic Acid Sales Price by Application (2027-2032) & (US$/Unit) Table 211. Europe Mefenamic Acid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. Europe Mefenamic Acid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. Europe Mefenamic Acid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. Europe Mefenamic Acid Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 215. Europe Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 216. Europe Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 217. Europe Mefenamic Acid Sales Price by Country (2021-2026) & (US$/Unit) Table 218. Europe Mefenamic Acid Sales Price by Country (2027-2032) & (US$/Unit) Table 219. Germany Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 220. France Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 221. U.K. Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 222. Italy Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 223. Netherlands Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 224. China Mefenamic Acid Revenue by Type (2021-2026) & (US$ Million) Table 225. China Mefenamic Acid Revenue by Type (2027-2032) & (US$ Million) Table 226. China Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 227. China Mefenamic Acid Sales by Type (2027-2032) & (K Units) Table 228. China Mefenamic Acid Sales Price by Type (2021-2026) & (US$/Unit) Table 229. China Mefenamic Acid Sales Price by Type (2027-2032) & (US$/Unit) Table 230. China Mefenamic Acid Revenue by Application (2021-2026) & (US$ Million) Table 231. China Mefenamic Acid Revenue by Application (2027-2032) & (US$ Million) Table 232. China Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 233. China Mefenamic Acid Sales by Application (2027-2032) & (K Units) Table 234. China Mefenamic Acid Sales Price by Application (2021-2026) & (US$/Unit) Table 235. China Mefenamic Acid Sales Price by Application (2027-2032) & (US$/Unit) Table 236. Asia Mefenamic Acid Revenue by Type (2021-2026) & (US$ Million) Table 237. Asia Mefenamic Acid Revenue by Type (2027-2032) & (US$ Million) Table 238. Asia Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 239. Asia Mefenamic Acid Sales by Type (2027-2032) & (K Units) Table 240. Asia Mefenamic Acid Sales Price by Type (2021-2026) & (US$/Unit) Table 241. Asia Mefenamic Acid Sales Price by Type (2027-2032) & (US$/Unit) Table 242. Asia Mefenamic Acid Revenue by Application (2021-2026) & (US$ Million) Table 243. Asia Mefenamic Acid Revenue by Application (2027-2032) & (US$ Million) Table 244. Asia Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 245. Asia Mefenamic Acid Sales by Application (2027-2032) & (K Units) Table 246. Asia Mefenamic Acid Sales Price by Application (2021-2026) & (US$/Unit) Table 247. Asia Mefenamic Acid Sales Price by Application (2027-2032) & (US$/Unit) Table 248. Asia Mefenamic Acid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 249. Asia Mefenamic Acid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 250. Asia Mefenamic Acid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 251. Asia Mefenamic Acid Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 252. Asia Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 253. Asia Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 254. Asia Mefenamic Acid Sales Price by Country (2021-2026) & (US$/Unit) Table 255. Asia Mefenamic Acid Sales Price by Country (2027-2032) & (US$/Unit) Table 256. Japan Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 257. South Korea Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 258. India Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 259. Australia Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 260. China Taiwan Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 261. Southeast Asia Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 262. SAMEA Mefenamic Acid Revenue by Type (2021-2026) & (US$ Million) Table 263. SAMEA Mefenamic Acid Revenue by Type (2027-2032) & (US$ Million) Table 264. SAMEA Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 265. SAMEA Mefenamic Acid Sales by Type (2027-2032) & (K Units) Table 266. SAMEA Mefenamic Acid Sales Price by Type (2021-2026) & (US$/Unit) Table 267. SAMEA Mefenamic Acid Sales Price by Type (2027-2032) & (US$/Unit) Table 268. SAMEA Mefenamic Acid Revenue by Application (2021-2026) & (US$ Million) Table 269. SAMEA Mefenamic Acid Revenue by Application (2027-2032) & (US$ Million) Table 270. SAMEA Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 271. SAMEA Mefenamic Acid Sales by Application (2027-2032) & (K Units) Table 272. SAMEA Mefenamic Acid Sales Price by Application (2021-2026) & (US$/Unit) Table 273. SAMEA Mefenamic Acid Sales Price by Application (2027-2032) & (US$/Unit) Table 274. SAMEA Mefenamic Acid Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 275. SAMEA Mefenamic Acid Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 276. SAMEA Mefenamic Acid Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 277. SAMEA Mefenamic Acid Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 278. SAMEA Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 279. SAMEA Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 280. SAMEA Mefenamic Acid Sales Price by Country (2021-2026) & (US$/Unit) Table 281. SAMEA Mefenamic Acid Sales Price by Country (2027-2032) & (US$/Unit) Table 282. Brazil Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 283. Argentina Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 284. Chile Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 285. Colombia Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 286. Peru Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 287. Saudi Arabia Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 288. Israel Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 289. UAE Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 290. Turkey Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 291. Iran Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 292. Egypt Mefenamic Acid Revenue (2021-2032) & (US$ Million) Table 293. Key Raw Materials Table 294. Raw Materials Key Suppliers Table 295. Mefenamic Acid Distributors List Table 296. Mefenamic Acid Customers List Table 297. Research Programs/Design for This Report Table 298. Authors List of This Report Table 299. Secondary Sources Table 300. Primary Sources List of Figures Figure 1. Mefenamic Acid Image Figure 2. Global Mefenamic Acid Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mefenamic Acid Market Size Share 2021 VS 2025 VS 2032 Figure 4. Patent Image Figure 5. Generic Image Figure 6. Global Mefenamic Acid Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Mefenamic Acid Market Size Share 2021 VS 2025 VS 2032 Figure 8. On-line Image Figure 9. Drug Store Image Figure 10. Hospital Image Figure 11. Global Mefenamic Acid Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Mefenamic Acid Revenue (2021-2032) & (US$ Million) Figure 13. Global Mefenamic Acid Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Mefenamic Acid Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Mefenamic Acid Revenue Market Share by Region (2021-2032) Figure 16. Global Mefenamic Acid Sales (2021-2032) & (K Units) Figure 17. Global Mefenamic Acid Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Mefenamic Acid Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Mefenamic Acid Sales YoY (2021-2032) & (K Units) Figure 20. Europe Mefenamic Acid Sales YoY (2021-2032) & (K Units) Figure 21. China Mefenamic Acid Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Mefenamic Acid Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Mefenamic Acid Sales YoY (2021-2032) & (K Units) Figure 24. Global Mefenamic Acid Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Mefenamic Acid Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Mefenamic Acid Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Mefenamic Acid Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Mefenamic Acid Revenue Market Share by Type (2021-2032) Figure 30. Global Mefenamic Acid Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Mefenamic Acid Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Mefenamic Acid Sales Market Share by Type (2021-2032) Figure 33. Global Mefenamic Acid Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Mefenamic Acid Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Mefenamic Acid Revenue Market Share by Application (2021-2032) Figure 36. Global Mefenamic Acid Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Mefenamic Acid Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Mefenamic Acid Sales Market Share by Application (2021-2032) Figure 39. North America Mefenamic Acid Revenue Share by Type (2021-2032) Figure 40. North America Mefenamic Acid Sales Share by Type (2021-2032) Figure 41. North America Mefenamic Acid Revenue Share by Application (2021-2032) Figure 42. North America Mefenamic Acid Sales Share by Application (2021-2032) Figure 43. North America Mefenamic Acid Revenue Share by Country (2021-2032) Figure 44. North America Mefenamic Acid Sales Share by Country (2021-2032) Figure 45. Europe Mefenamic Acid Revenue Share by Type (2021-2032) Figure 46. Europe Mefenamic Acid Sales Share by Type (2021-2032) Figure 47. Europe Mefenamic Acid Revenue Share by Application (2021-2032) Figure 48. Europe Mefenamic Acid Sales Share by Application (2021-2032) Figure 49. Europe Mefenamic Acid Revenue Share by Country (2021-2032) Figure 50. Europe Mefenamic Acid Sales Share by Country (2021-2032) Figure 51. China Mefenamic Acid Revenue Share by Type (2021-2032) Figure 52. China Mefenamic Acid Sales Share by Type (2021-2032) Figure 53. China Mefenamic Acid Revenue Share by Application (2021-2032) Figure 54. China Mefenamic Acid Sales Share by Application (2021-2032) Figure 55. Asia Mefenamic Acid Revenue Share by Type (2021-2032) Figure 56. Asia Mefenamic Acid Sales Share by Type (2021-2032) Figure 57. Asia Mefenamic Acid Revenue Share by Application (2021-2032) Figure 58. Asia Mefenamic Acid Sales Share by Application (2021-2032) Figure 59. Asia Mefenamic Acid Revenue Share by Country (2021-2032) Figure 60. Asia Mefenamic Acid Sales Share by Country (2021-2032) Figure 61. SAMEA Mefenamic Acid Revenue Share by Type (2021-2032) Figure 62. SAMEA Mefenamic Acid Sales Share by Type (2021-2032) Figure 63. SAMEA Mefenamic Acid Revenue Share by Application (2021-2032) Figure 64. SAMEA Mefenamic Acid Sales Share by Application (2021-2032) Figure 65. SAMEA Mefenamic Acid Revenue Share by Country (2021-2032) Figure 66. SAMEA Mefenamic Acid Sales Share by Country (2021-2032) Figure 67. Mefenamic Acid Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Mefenamic Acid Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Patent
  • Generic
Applications
  • On-line
  • Drug Store
  • Hospital
Companies covered
  • AA Pharma
  • ABL Lifecare
  • Adelco
  • Agron Remedies
  • Apotex
  • Captab
  • Chemidex Pharma
  • Daiichi Sankyo
  • EMS Pharma
  • Esteve
  • Farmo Quimica
  • IASIS Pharmaceuticals Hellas
  • Koa Isei
  • Mankind
  • Nisshin Pharmaceutical
  • Sanofi Aventis
  • Shinto Organics
  • Shionogi Pharma
  • Solitaire Pharmacia
  • Streuli Pharma,
  • Wockhardt
  • Yung Sine
  • Pfizer
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Mefenamic Acid Market by Type
  3. 1.2.1 Global Mefenamic Acid Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Patent
  5. 1.2.3 Generic
  6. 1.3 Mefenamic Acid Market by Application
  7. 1.3.1 Global Mefenamic Acid Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 On-line
  9. 1.3.3 Drug Store
  10. 1.3.4 Hospital
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Mefenamic Acid Market Dynamics
  1. 2.1 Mefenamic Acid Industry Trends
  2. 2.2 Mefenamic Acid Industry Drivers
  3. 2.3 Mefenamic Acid Industry Opportunities and Challenges
  4. 2.4 Mefenamic Acid Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Mefenamic Acid Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Mefenamic Acid Revenue by Region
  3. 3.2.1 Global Mefenamic Acid Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Mefenamic Acid Revenue by Region (2021-2026)
  5. 3.2.3 Global Mefenamic Acid Revenue by Region (2027-2032)
  6. 3.2.4 Global Mefenamic Acid Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Mefenamic Acid Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Mefenamic Acid Sales by Region
  9. 3.4.1 Global Mefenamic Acid Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Mefenamic Acid Sales by Region (2021-2026)
  11. 3.4.3 Global Mefenamic Acid Sales by Region (2027-2032)
  12. 3.4.4 Global Mefenamic Acid Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Mefenamic Acid Revenue by Manufacturers
  2. 4.1.1 Global Mefenamic Acid Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Mefenamic Acid Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Mefenamic Acid Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Mefenamic Acid Sales by Manufacturers
  6. 4.2.1 Global Mefenamic Acid Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Mefenamic Acid Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Mefenamic Acid Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Mefenamic Acid Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Mefenamic Acid Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Mefenamic Acid Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Mefenamic Acid Manufacturers, Product Type & Application
  13. 4.7 Global Mefenamic Acid Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Mefenamic Acid Market CR5 and HHI
  16. 4.8.2 2025 Mefenamic Acid Tier 1, Tier 2, and Tier 3
5 Mefenamic Acid Market by Type
  1. 5.1 Global Mefenamic Acid Revenue by Type
  2. 5.1.1 Global Mefenamic Acid Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Mefenamic Acid Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Mefenamic Acid Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Mefenamic Acid Sales by Type
  6. 5.2.1 Global Mefenamic Acid Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mefenamic Acid Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Mefenamic Acid Sales Market Share by Type (2021-2032)
  9. 5.3 Global Mefenamic Acid Price by Type
6 Mefenamic Acid Market by Application
  1. 6.1 Global Mefenamic Acid Revenue by Application
  2. 6.1.1 Global Mefenamic Acid Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Mefenamic Acid Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Mefenamic Acid Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Mefenamic Acid Sales by Application
  6. 6.2.1 Global Mefenamic Acid Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Mefenamic Acid Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Mefenamic Acid Sales Market Share by Application (2021-2032)
  9. 6.3 Global Mefenamic Acid Price by Application
7 Company Profiles
  1. 7.1 AA Pharma
  2. 7.1.1 AA Pharma Company Information
  3. 7.1.2 AA Pharma Business Overview
  4. 7.1.3 AA Pharma Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AA Pharma Mefenamic Acid Product Portfolio
  6. 7.1.5 AA Pharma Recent Developments
  7. 7.2 ABL Lifecare
  8. 7.2.1 ABL Lifecare Company Information
  9. 7.2.2 ABL Lifecare Business Overview
  10. 7.2.3 ABL Lifecare Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 ABL Lifecare Mefenamic Acid Product Portfolio
  12. 7.2.5 ABL Lifecare Recent Developments
  13. 7.3 Adelco
  14. 7.3.1 Adelco Company Information
  15. 7.3.2 Adelco Business Overview
  16. 7.3.3 Adelco Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Adelco Mefenamic Acid Product Portfolio
  18. 7.3.5 Adelco Recent Developments
  19. 7.4 Agron Remedies
  20. 7.4.1 Agron Remedies Company Information
  21. 7.4.2 Agron Remedies Business Overview
  22. 7.4.3 Agron Remedies Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Agron Remedies Mefenamic Acid Product Portfolio
  24. 7.4.5 Agron Remedies Recent Developments
  25. 7.5 Apotex
  26. 7.5.1 Apotex Company Information
  27. 7.5.2 Apotex Business Overview
  28. 7.5.3 Apotex Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Apotex Mefenamic Acid Product Portfolio
  30. 7.5.5 Apotex Recent Developments
  31. 7.6 Captab
  32. 7.6.1 Captab Company Information
  33. 7.6.2 Captab Business Overview
  34. 7.6.3 Captab Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Captab Mefenamic Acid Product Portfolio
  36. 7.6.5 Captab Recent Developments
  37. 7.7 Chemidex Pharma
  38. 7.7.1 Chemidex Pharma Company Information
  39. 7.7.2 Chemidex Pharma Business Overview
  40. 7.7.3 Chemidex Pharma Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Chemidex Pharma Mefenamic Acid Product Portfolio
  42. 7.7.5 Chemidex Pharma Recent Developments
  43. 7.8 Daiichi Sankyo
  44. 7.8.1 Daiichi Sankyo Company Information
  45. 7.8.2 Daiichi Sankyo Business Overview
  46. 7.8.3 Daiichi Sankyo Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Daiichi Sankyo Mefenamic Acid Product Portfolio
  48. 7.8.5 Daiichi Sankyo Recent Developments
  49. 7.9 EMS Pharma
  50. 7.9.1 EMS Pharma Company Information
  51. 7.9.2 EMS Pharma Business Overview
  52. 7.9.3 EMS Pharma Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 EMS Pharma Mefenamic Acid Product Portfolio
  54. 7.9.5 EMS Pharma Recent Developments
  55. 7.10 Esteve
  56. 7.10.1 Esteve Company Information
  57. 7.10.2 Esteve Business Overview
  58. 7.10.3 Esteve Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Esteve Mefenamic Acid Product Portfolio
  60. 7.10.5 Esteve Recent Developments
  61. 7.11 Farmo Quimica
  62. 7.11.1 Farmo Quimica Company Information
  63. 7.11.2 Farmo Quimica Business Overview
  64. 7.11.3 Farmo Quimica Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Farmo Quimica Mefenamic Acid Product Portfolio
  66. 7.11.5 Farmo Quimica Recent Developments
  67. 7.12 IASIS Pharmaceuticals Hellas
  68. 7.12.1 IASIS Pharmaceuticals Hellas Company Information
  69. 7.12.2 IASIS Pharmaceuticals Hellas Business Overview
  70. 7.12.3 IASIS Pharmaceuticals Hellas Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolio
  72. 7.12.5 IASIS Pharmaceuticals Hellas Recent Developments
  73. 7.13 Koa Isei
  74. 7.13.1 Koa Isei Company Information
  75. 7.13.2 Koa Isei Business Overview
  76. 7.13.3 Koa Isei Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Koa Isei Mefenamic Acid Product Portfolio
  78. 7.13.5 Koa Isei Recent Developments
  79. 7.14 Mankind
  80. 7.14.1 Mankind Company Information
  81. 7.14.2 Mankind Business Overview
  82. 7.14.3 Mankind Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Mankind Mefenamic Acid Product Portfolio
  84. 7.14.5 Mankind Recent Developments
  85. 7.15 Nisshin Pharmaceutical
  86. 7.15.1 Nisshin Pharmaceutical Company Information
  87. 7.15.2 Nisshin Pharmaceutical Business Overview
  88. 7.15.3 Nisshin Pharmaceutical Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Nisshin Pharmaceutical Mefenamic Acid Product Portfolio
  90. 7.15.5 Nisshin Pharmaceutical Recent Developments
  91. 7.16 Sanofi Aventis
  92. 7.16.1 Sanofi Aventis Company Information
  93. 7.16.2 Sanofi Aventis Business Overview
  94. 7.16.3 Sanofi Aventis Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Sanofi Aventis Mefenamic Acid Product Portfolio
  96. 7.16.5 Sanofi Aventis Recent Developments
  97. 7.17 Shinto Organics
  98. 7.17.1 Shinto Organics Company Information
  99. 7.17.2 Shinto Organics Business Overview
  100. 7.17.3 Shinto Organics Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Shinto Organics Mefenamic Acid Product Portfolio
  102. 7.17.5 Shinto Organics Recent Developments
  103. 7.18 Shionogi Pharma
  104. 7.18.1 Shionogi Pharma Company Information
  105. 7.18.2 Shionogi Pharma Business Overview
  106. 7.18.3 Shionogi Pharma Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Shionogi Pharma Mefenamic Acid Product Portfolio
  108. 7.18.5 Shionogi Pharma Recent Developments
  109. 7.19 Solitaire Pharmacia
  110. 7.19.1 Solitaire Pharmacia Company Information
  111. 7.19.2 Solitaire Pharmacia Business Overview
  112. 7.19.3 Solitaire Pharmacia Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Solitaire Pharmacia Mefenamic Acid Product Portfolio
  114. 7.19.5 Solitaire Pharmacia Recent Developments
  115. 7.20 Streuli Pharma,
  116. 7.20.1 Streuli Pharma, Company Information
  117. 7.20.2 Streuli Pharma, Business Overview
  118. 7.20.3 Streuli Pharma, Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Streuli Pharma, Mefenamic Acid Product Portfolio
  120. 7.20.5 Streuli Pharma, Recent Developments
  121. 7.21 Wockhardt
  122. 7.21.1 Wockhardt Company Information
  123. 7.21.2 Wockhardt Business Overview
  124. 7.21.3 Wockhardt Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Wockhardt Mefenamic Acid Product Portfolio
  126. 7.21.5 Wockhardt Recent Developments
  127. 7.22 Yung Sine
  128. 7.22.1 Yung Sine Company Information
  129. 7.22.2 Yung Sine Business Overview
  130. 7.22.3 Yung Sine Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Yung Sine Mefenamic Acid Product Portfolio
  132. 7.22.5 Yung Sine Recent Developments
  133. 7.23 Pfizer
  134. 7.23.1 Pfizer Company Information
  135. 7.23.2 Pfizer Business Overview
  136. 7.23.3 Pfizer Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Pfizer Mefenamic Acid Product Portfolio
  138. 7.23.5 Pfizer Recent Developments
  139. 7.24 Teva
  140. 7.24.1 Teva Company Information
  141. 7.24.2 Teva Business Overview
  142. 7.24.3 Teva Mefenamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Teva Mefenamic Acid Product Portfolio
  144. 7.24.5 Teva Recent Developments
8 North America
  1. 8.1 North America Mefenamic Acid Market Size by Type
  2. 8.1.1 North America Mefenamic Acid Revenue by Type (2021-2032)
  3. 8.1.2 North America Mefenamic Acid Sales by Type (2021-2032)
  4. 8.1.3 North America Mefenamic Acid Price by Type (2021-2032)
  5. 8.2 North America Mefenamic Acid Market Size by Application
  6. 8.2.1 North America Mefenamic Acid Revenue by Application (2021-2032)
  7. 8.2.2 North America Mefenamic Acid Sales by Application (2021-2032)
  8. 8.2.3 North America Mefenamic Acid Price by Application (2021-2032)
  9. 8.3 North America Mefenamic Acid Market Size by Country
  10. 8.3.1 North America Mefenamic Acid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Mefenamic Acid Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Mefenamic Acid Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Mefenamic Acid Market Size by Type
  2. 9.1.1 Europe Mefenamic Acid Revenue by Type (2021-2032)
  3. 9.1.2 Europe Mefenamic Acid Sales by Type (2021-2032)
  4. 9.1.3 Europe Mefenamic Acid Price by Type (2021-2032)
  5. 9.2 Europe Mefenamic Acid Market Size by Application
  6. 9.2.1 Europe Mefenamic Acid Revenue by Application (2021-2032)
  7. 9.2.2 Europe Mefenamic Acid Sales by Application (2021-2032)
  8. 9.2.3 Europe Mefenamic Acid Price by Application (2021-2032)
  9. 9.3 Europe Mefenamic Acid Market Size by Country
  10. 9.3.1 Europe Mefenamic Acid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Mefenamic Acid Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Mefenamic Acid Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Mefenamic Acid Market Size by Type
  2. 10.1.1 China Mefenamic Acid Revenue by Type (2021-2032)
  3. 10.1.2 China Mefenamic Acid Sales by Type (2021-2032)
  4. 10.1.3 China Mefenamic Acid Price by Type (2021-2032)
  5. 10.2 China Mefenamic Acid Market Size by Application
  6. 10.2.1 China Mefenamic Acid Revenue by Application (2021-2032)
  7. 10.2.2 China Mefenamic Acid Sales by Application (2021-2032)
  8. 10.2.3 China Mefenamic Acid Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Mefenamic Acid Market Size by Type
  2. 11.1.1 Asia Mefenamic Acid Revenue by Type (2021-2032)
  3. 11.1.2 Asia Mefenamic Acid Sales by Type (2021-2032)
  4. 11.1.3 Asia Mefenamic Acid Price by Type (2021-2032)
  5. 11.2 Asia Mefenamic Acid Market Size by Application
  6. 11.2.1 Asia Mefenamic Acid Revenue by Application (2021-2032)
  7. 11.2.2 Asia Mefenamic Acid Sales by Application (2021-2032)
  8. 11.2.3 Asia Mefenamic Acid Price by Application (2021-2032)
  9. 11.3 Asia Mefenamic Acid Market Size by Country
  10. 11.3.1 Asia Mefenamic Acid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Mefenamic Acid Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Mefenamic Acid Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Mefenamic Acid Market Size by Type
  2. 12.1.1 SAMEA Mefenamic Acid Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Mefenamic Acid Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Mefenamic Acid Price by Type (2021-2032)
  5. 12.2 SAMEA Mefenamic Acid Market Size by Application
  6. 12.2.1 SAMEA Mefenamic Acid Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Mefenamic Acid Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Mefenamic Acid Price by Application (2021-2032)
  9. 12.3 SAMEA Mefenamic Acid Market Size by Country
  10. 12.3.1 SAMEA Mefenamic Acid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Mefenamic Acid Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Mefenamic Acid Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Mefenamic Acid Value Chain Analysis
  2. 13.1.1 Mefenamic Acid Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Mefenamic Acid Production Mode & Process
  6. 13.2 Mefenamic Acid Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Mefenamic Acid Distributors
  9. 13.2.3 Mefenamic Acid Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research